Symbiome, Inc. — Form D
Symbiome, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2020-06-19. The offering totals $8.0M, of which $7.2M was reported sold. Industry: Other.
Offering
- Filed: 2020-06-19
- Form: D
- Accession: 0001815492-20-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $8.0M
- Amount sold: $7.2M
- Remaining: $825K
- Minimum investment: $12K
- Investors: 10
- Date of first sale: 2020-06-05
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-369371
Issuer
- Name: Symbiome, Inc.
- CIK: 0001815492
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 953 INDIANA STREET, SAN FRANCISCO, CA, 94107
- Phone: (415) 812-8600
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Adam D'Augelli | Director | Boston, MA |
| Larry Weiss | Director | Boston, MA |
| Larry Weiss | Executive Officer | Boston, MA |
| Adam Klausner | Executive Officer | San Francisco, CA |
| Vicki Levine | Director | San Francisco, CA |
| Vicki Levine | Executive Officer | San Francisco, CA |
Other filings by this issuer (1)
More